North Total Operating Expenses vs Total Revenue Analysis

000059 Stock

5.23 0.17 3.15%

North Huajin financial indicator trend analysis is infinitely more than just investigating North Huajin Chemical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether North Huajin Chemical is a good investment. Please check the relationship between North Huajin Total Operating Expenses and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in North Huajin Chemical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Total Operating Expenses vs Total Revenue

Total Operating Expenses vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of North Huajin Chemical Total Operating Expenses account and Total Revenue. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between North Huajin's Total Operating Expenses and Total Revenue is 0.48. Overlapping area represents the amount of variation of Total Operating Expenses that can explain the historical movement of Total Revenue in the same time period over historical financial statements of North Huajin Chemical, assuming nothing else is changed. The correlation between historical values of North Huajin's Total Operating Expenses and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Operating Expenses of North Huajin Chemical are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Total Operating Expenses i.e., North Huajin's Total Operating Expenses and Total Revenue go up and down completely randomly.

Correlation Coefficient

0.48

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.

Total Revenue

Total revenue comprises all receipts North Huajin Chemical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from North Huajin's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into North Huajin Chemical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in North Huajin Chemical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Selling General Administrative is expected to grow to about 784.2 M, whereas Tax Provision is forecasted to decline to about 68 M.

	2021	2022	2023	2024 (projected)
Operating Income	1.8B	1.3B	481.3M	457.3M
Total Revenue	38.6B	49.1B	46.1B	24.3B

Operating Income Total Revenue

North Huajin fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Long Term Debt	Net Receivables	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Retained Earnings	Net Tangible Assets	Short Term Investments	Other Stockholder Equity	Deferred Long Term Liab	Long Term Investments	Short Long Term Debt	Total Current Assets	Short Term Debt	Non Current Assets Total
Total Assets		0.48	0.63	0.72	0.7	0.34	0.47	0.31	0.46	0.16	0.84	0.49	0.86	0.61	0.8	0.76	0.48	0.29	-0.17	-0.11	0.07	0.25	0.21	0.31	0.27	-0.17
Other Current Liab	0.48		0.56	-0.04	0.13	0.21	-0.24	-0.27	0.29	0.11	0.59	0.32	0.7	-0.07	-0.04	0.67	-0.16	-0.44	0.3	0.31	-0.23	-0.54	-0.12	-0.34	-0.37	0.47
Total Current Liabilities	0.63	0.56		0.05	0.36	0.1	-0.18	0.33	-0.21	0.41	0.51	0.18	0.84	0.46	0.33	0.77	-0.26	-0.42	0.45	0.56	-0.46	-0.41	0.41	-0.34	0.08	0.49
Total Stockholder Equity	0.72	-0.04	0.05		0.77	0.12	0.83	0.39	0.4	-0.04	0.46	0.64	0.27	0.68	0.89	0.14	0.91	0.81	-0.63	-0.51	0.35	0.73	0.29	0.76	0.61	-0.64
Other Liab	0.7	0.13	0.36	0.77		0.1	0.57	0.4	0.11	0.08	0.49	0.46	0.41	0.61	0.76	0.33	0.64	0.52	-0.53	-0.13	0.05	0.49	0.51	0.46	0.65	-0.36
Accounts Payable	0.34	0.21	0.1	0.12	0.1		0.24	-0.01	0.51	-0.32	0.48	0.02	0.39	-0.2	0.11	0.38	0.12	0.17	-0.07	-0.32	0.43	0.24	-0.23	0.26	0.0	-0.29
Cash	0.47	-0.24	-0.18	0.83	0.57	0.24		0.31	0.42	-0.1	0.34	0.41	0.05	0.43	0.67	-0.1	0.83	0.92	-0.81	-0.8	0.69	0.87	0.05	0.92	0.58	-0.92
Other Assets	0.31	-0.27	0.33	0.39	0.4	-0.01	0.31		-0.31	-0.04	-0.04	0.22	0.14	0.72	0.59	0.0	0.16	0.27	-0.05	-0.08	0.16	0.27	0.39	0.31	0.53	-0.2
Long Term Debt	0.46	0.29	-0.21	0.4	0.11	0.51	0.42	-0.31		-0.17	0.6	0.12	0.35	-0.14	0.26	0.38	0.46	0.37	-0.37	-0.54	0.48	0.37	-0.51	0.38	-0.26	-0.42
Net Receivables	0.16	0.11	0.41	-0.04	0.08	-0.32	-0.1	-0.04	-0.17		0.06	-0.05	0.25	0.43	0.18	0.24	-0.24	-0.27	0.09	0.45	-0.47	-0.24	0.26	-0.22	-0.11	0.32
Inventory	0.84	0.59	0.51	0.46	0.49	0.48	0.34	-0.04	0.6	0.06		0.2	0.83	0.21	0.52	0.72	0.29	0.18	-0.1	-0.15	0.18	0.19	-0.06	0.23	0.0	-0.12
Other Current Assets	0.49	0.32	0.18	0.64	0.46	0.02	0.41	0.22	0.12	-0.05	0.2		0.21	0.44	0.41	0.07	0.63	0.35	-0.26	-0.08	-0.04	0.17	0.44	0.42	0.44	-0.15
Total Liab	0.86	0.7	0.84	0.27	0.41	0.39	0.05	0.14	0.35	0.25	0.83	0.21		0.35	0.46	0.95	0.0	-0.19	0.23	0.22	-0.16	-0.19	0.08	-0.13	-0.07	0.23
Intangible Assets	0.61	-0.07	0.46	0.68	0.61	-0.2	0.43	0.72	-0.14	0.43	0.21	0.44	0.35		0.87	0.21	0.37	0.33	-0.18	-0.01	-0.07	0.29	0.48	0.32	0.5	-0.16
Common Stock	0.8	-0.04	0.33	0.89	0.76	0.11	0.67	0.59	0.26	0.18	0.52	0.41	0.46	0.87		0.33	0.63	0.61	-0.39	-0.32	0.23	0.59	0.31	0.57	0.53	-0.45
Property Plant Equipment	0.76	0.67	0.77	0.14	0.33	0.38	-0.1	0.0	0.38	0.24	0.72	0.07	0.95	0.21	0.33		-0.09	-0.31	0.28	0.31	-0.27	-0.28	0.03	-0.29	-0.19	0.33
Retained Earnings	0.48	-0.16	-0.26	0.91	0.64	0.12	0.83	0.16	0.46	-0.24	0.29	0.63	0.0	0.37	0.63	-0.09		0.89	-0.77	-0.61	0.41	0.8	0.23	0.82	0.6	-0.75
Net Tangible Assets	0.29	-0.44	-0.42	0.81	0.52	0.17	0.92	0.27	0.37	-0.27	0.18	0.35	-0.19	0.33	0.61	-0.31	0.89		-0.82	-0.8	0.67	0.97	0.11	0.95	0.64	-0.94
Short Term Investments	-0.17	0.3	0.45	-0.63	-0.53	-0.07	-0.81	-0.05	-0.37	0.09	-0.1	-0.26	0.23	-0.18	-0.39	0.28	-0.77	-0.82		0.69	-0.5	-0.76	0.07	-0.74	-0.36	0.83
Other Stockholder Equity	-0.11	0.31	0.56	-0.51	-0.13	-0.32	-0.8	-0.08	-0.54	0.45	-0.15	-0.08	0.22	-0.01	-0.32	0.31	-0.61	-0.8	0.69		-0.93	-0.77	0.45	-0.79	-0.2	0.92
Deferred Long Term Liab	0.07	-0.23	-0.46	0.35	0.05	0.43	0.69	0.16	0.48	-0.47	0.18	-0.04	-0.16	-0.07	0.23	-0.27	0.41	0.67	-0.5	-0.93		0.67	-0.46	0.73	0.19	-0.83
Long Term Investments	0.25	-0.54	-0.41	0.73	0.49	0.24	0.87	0.27	0.37	-0.24	0.19	0.17	-0.19	0.29	0.59	-0.28	0.8	0.97	-0.76	-0.77	0.67		0.09	0.91	0.62	-0.92
Short Long Term Debt	0.21	-0.12	0.41	0.29	0.51	-0.23	0.05	0.39	-0.51	0.26	-0.06	0.44	0.08	0.48	0.31	0.03	0.23	0.11	0.07	0.45	-0.46	0.09		0.1	0.76	0.14
Total Current Assets	0.31	-0.34	-0.34	0.76	0.46	0.26	0.92	0.31	0.38	-0.22	0.23	0.42	-0.13	0.32	0.57	-0.29	0.82	0.95	-0.74	-0.79	0.73	0.91	0.1		0.62	-0.91
Short Term Debt	0.27	-0.37	0.08	0.61	0.65	0.0	0.58	0.53	-0.26	-0.11	0.0	0.44	-0.07	0.5	0.53	-0.19	0.6	0.64	-0.36	-0.2	0.19	0.62	0.76	0.62		-0.48
Non Current Assets Total	-0.17	0.47	0.49	-0.64	-0.36	-0.29	-0.92	-0.2	-0.42	0.32	-0.12	-0.15	0.23	-0.16	-0.45	0.33	-0.75	-0.94	0.83	0.92	-0.83	-0.92	0.14	-0.91	-0.48

Click cells to compare fundamentals

North Huajin Account Relationship Matchups

North Huajin fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	29.4B	27.9B	32.1B	32.6B	31.9B	22.7B
Other Current Liab	816.4M	629.3M	2.5B	1.9B	79.5M	75.5M
Total Current Liabilities	9.0B	7.5B	7.7B	11.3B	6.8B	9.0B
Total Stockholder Equity	13.6B	13.5B	14.3B	14.4B	14.3B	8.3B
Other Liab	301.2M	296.0M	307.1M	280.9M	323.0M	217.3M
Accounts Payable	1.2B	856.1M	2.1B	2.9B	3.8B	3.9B
Cash	7.1B	7.8B	9.6B	10.0B	9.4B	9.9B
Other Assets	573.0M	695.4M	999.6M	930.4M	1.1B	1.1B
Long Term Debt	6.0B	5.9B	10.0B	5.9B	9.8B	5.1B
Net Receivables	532.6M	190.5M	256.9M	103.3M	170.5M	327.5M
Inventory	3.7B	2.8B	4.5B	5.1B	5.8B	2.9B
Other Current Assets	1.8B	2.0B	3.1B	3.2B	30.4M	28.9M
Total Liab	15.2B	13.8B	17.2B	17.5B	16.9B	14.2B
Intangible Assets	1.3B	1.3B	1.2B	1.2B	1.1B	723.7M
Property Plant Equipment	14.1B	13.0B	13.0B	11.9B	13.6B	12.3B
Retained Earnings	6.0B	6.0B	6.2B	5.7B	5.6B	3.0B
Net Tangible Assets	12.3B	12.3B	13.1B	13.2B	15.2B	12.3B
Other Stockholder Equity	47.8M	26.3M	6.1M	8.7K	7.8K	7.4K
Deferred Long Term Liab	133.4M	232.5M	527.0M	463.2M	532.6M	559.3M
Short Long Term Debt	6.7B	1.6B	1.4B	1.0B	1.0B	950.6M
Total Current Assets	13.3B	12.9B	17.8B	18.6B	19.2B	16.2B
Non Current Assets Total	16.0B	15.0B	14.6B	14.1B	12.7B	12.5B
Non Currrent Assets Other	162.0M	169.6M	164.3M	159.7M	247.0M	337.6M
Non Current Liabilities Total	6.2B	6.3B	10.4B	6.3B	10.1B	6.9B
Non Current Liabilities Other	53.0M	8.7B	5.8B	144.0M	120.9M	114.8M
Net Debt	5.1B	5.3B	1.8B	1.3B	1.2B	1.1B
Net Invested Capital	26.1B	21.1B	25.6B	21.3B	25.1B	19.6B
Net Working Capital	4.3B	5.4B	10.7B	7.3B	12.4B	6.7B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Other Information on Investing in North Stock

Balance Sheet is a snapshot of the financial position of North Huajin Chemical at a specified time, usually calculated after every quarter, six months, or one year. North Huajin Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of North Huajin and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which North currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

North Total Operating Expenses vs Total Revenue Analysis

Total Operating Expenses vs Total Revenue

Total Operating Expenses vs Total Revenue Correlation Analysis

Correlation Coefficient

Total Operating Expenses

Total Revenue

North Huajin fundamental ratios Correlations

North Huajin Account Relationship Matchups

High Positive Relationship

High Negative Relationship

North Huajin fundamental ratios Accounts

Also Currently Popular

Other Information on Investing in North Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Long Term Investments	+ 0.97	Net Tangible Assets
Property Plant Equipment	+ 0.95	Total Liab
Total Current Assets	+ 0.95	Net Tangible Assets
Net Tangible Assets	+ 0.92	Cash
Total Current Assets	+ 0.92	Cash
Non Current Assets Total	+ 0.92	Other Stockholder Equity

Non Current Assets Total	- 0.94	Net Tangible Assets
Deferred Long Term Liab	- 0.93	Other Stockholder Equity
Non Current Assets Total	- 0.92	Long Term Investments
Non Current Assets Total	- 0.92	Cash
Non Current Assets Total	- 0.91	Total Current Assets
Non Current Assets Total	- 0.83	Deferred Long Term Liab